Second Annual Meeting of the Oligonucleotide Therapeutics Society October 19-21, 2006

Second Annual Meeting of the Oligonucleotide Therapeutics Society October 19-21, 2006
New York, NY
Oligonucleotide-based gene-silencing techniques are emerging as important tools for targeting specific genes for research and innovative therapeutics. This meeting, sponsored by the New York Academy of Sciences and the Oligonucleotide Therapeutics Society, will integrate basic science, drug discovery, and preclinical and clinical research, so that those working in academic and industry settings can develop a mutual understanding of the various technologies offered and their applications in both scientific research and as therapeutic agents.
Special sessions are devoted to:
Cell biology and enzymology of mRNA metabolism and oligonucleotide function
Oligonucleotide synthesis and technologies
Gene targeting
Immunomodulation
Novel and alternative gene targeting technologies
212.838.0230